The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and tissues from patients with fatal IPF. The researchers discovered that disease ...

Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have spent decades investigating what causes the distinctive scarring pattern in IPF lungs without finding a definitive answer. While no single cause has been identified, several ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

Idiopathic pulmonary fibrosis (IPF) scars lung tissue and makes breathing increasingly difficult until patients can't get enough oxygen. Available drugs provide minimal benefit. Lung ...

When the scarring is in the tissues of the lung, these are called “sequelae” or fibrotic changes, which can lead to loss of lung function. The loss of lung function can manifest with shortness ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...